Fellow

John Neoptolemos, Professor of Surgery and Head of School of Cancer Studies, University of Liverpool, leads one of the most successful clinical and academic surgical/oncology programmes in the UK. He is internationally regarded for his achievements in the areas of new therapies for pancreatic cancer, pre-symptomatic diagnosis, prognostic and biological predictors of treatment response to pancreatic cancer, clinical trials of pancreatic cancer, hereditary and chronic pancreatitis and acute pancreatitis. He was the founder of European Study for Pancreas Cancer Research (ESPAC) that has led the way for internationally collaborative pancreas cancer trials and now also includes the NCI’s of Canada and Japan and the MRC of Australia. In 1997 he established the European Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC), a major resource and focus for the study of genetic pancreas diseases. Since 2005 he has headed the highly successful School of Cancer Studies now duly recognised as one of the world’s leading pancreas and clinical cancer research centres